Greenphire's John Samar Named CFO of the Year Finalist
News May 29, 2013
Greenphire announces that the company's CFO, John Samar, has been named as a finalist in the Philadelphia Business Journal's CFO of the Year Award program.
This award marks the latest in a hat-trick of industry recognitions for Greenphire, with CEO Sam Whitaker recently being announced as a finalist in the Ernst & Young Entrepreneur of the Year Awards, and Shawn Milochik, Vice President of Software Engineering, awarded the Philadelphia Business Journal's Top IT Innovator Award.
John Samar, CFO and co-founder of Greenphire, comments, "I am proud to have been selected as a finalist and to have been acknowledged alongside some of our region's most distinguished and talented CFOs. As Greenphire continues its ambitious international growth strategy, this recognizes the accomplishments of our entire team, beginning as a two-person start-up and growing to become one of the leading providers of clinical payment technologies."
John co-founded Greenphire in 2008 and under his financial management and leadership the company has experienced phenomenal year-on-year growth and currently works with multiple top 30 pharmaceutical companies. In the last 12 months alone, Greenphire has more than doubled its team and launched its first international office in London.
All award finalists will be recognized and winners announced at a ceremony on July 11.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Microbiotica Enters into Microbiome Collaboration with GenentechNews
Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.READ MORE